NCT04485884 - A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

June 30, 2021

Conditions

Healthy

Interventions

DRUG

IN-C005 dose A

One time dose of IN-C005 dose A taken orally.

DRUG

IN-C005 dose B

One time dose of IN-C005 dose B taken orally.

DRUG

IN-C005 dose C

One time dose of IN-C005 dose C taken orally.

DRUG

IN-C005 dose D

Oral administration of IN-C005 dose D once daily for 7 days.

DRUG

IN-C005 dose E

Oral administration of IN-C005 dose E once daily for 7 days.

DRUG

IN-C005 dose F

Oral administration of IN-C005 dose F once daily for 7 days.

Trial Locations (1)

RECRUITING

Seoul National University Hospital, Seoul